43 results match your criteria: "New York University Fertility Center[Affiliation]"
F S Rep
December 2022
The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, New York, New York.
Objective: To analyze the use of services regarding fertility preservation (FP) in cancer patients at a single institution.
Design: A retrospective cohort study.
Setting: Academic medical center.
J Assist Reprod Genet
October 2020
Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NBV 9E-2, New York, NY, 10016, USA.
Purpose: The objective of this study was to investigate stress levels among women undergoing elective oocyte cryopreservation by comparing their self-reported quality of life measures with women undergoing in vitro fertilization during the fertility treatment cycle.
Methods: Patients undergoing oocyte retrieval at a single institution were offered a voluntary, anonymous, and written questionnaire. The survey was adapted and validated from the Fertility Quality of Life tool to assess self-reported fertility treatment-related problems and was tested for construct validity and reliability.
Eur J Med Genet
August 2019
CooperGenomics, Livingston, NJ, USA; Yale University, Dept. Ob. Gyn. and Reprod Sci, New Heaven, CT, USA.
Although oocyte donors are young and are expected to provide a high rate of euploid oocytes, significant differences of euploidy rates for donor embryos exist between different IVF centers (1). Laboratory conditions can lead to differences of euploidy (2,3,4,5,6,7); but, the role of COH has not been investigated. In this study, we investigated whether euploidy rates in the embryos created from donor oocytes are influenced by controlled ovarian hyperstimulation parameters used during assisted reproduction.
View Article and Find Full Text PDFReprod Sci
December 2019
New York University Fertility Center, New York, NY, USA.
Two of the many milestone developments in the field of assisted reproduction have been oocyte donation and preimplantation genetic testing for aneuploidy (PGT-A). Because it has been demonstrated that even young women produce a meaningful proportion of aneuploid embryos, screening out such abnormalities could potentially increase the efficacy of donor egg (DE) cycles. In this retrospective cohort study, we investigated the effect of PGT-A on DE cycle outcomes, including implantation rate (IR), spontaneous abortion rate (SABR), and ongoing pregnancy/live birth rate.
View Article and Find Full Text PDFReprod Biol Endocrinol
April 2017
New York University Fertility Center, New York University School of Medicine, 660 First Avenue, 5th floor, New York, 10016, NY, USA.
Reprod Biol Endocrinol
April 2017
New York University Fertility Center, New York University School of Medicine, 660 First Avenue, 5th floor, New York, 10016, NY, USA.
Gynecol Endocrinol
June 2017
b Obstetrics and Gynecology , New York University Langone Medical Center, New York , NY , USA.
Resident physicians' scores on the REI section of the CREOG exam are traditionally low, and nearly 40% of house staff nation-wide perceive their REI knowledge to be poor. We aimed to assess whether an interactive case-based group-learning curriculum would narrow the REI knowledge gap by improving understanding and retention of core REI concepts under the time constraints affecting residents. A three-hour case-based workshop was developed to address four primary CREOG objectives.
View Article and Find Full Text PDFReprod Biomed Online
April 2017
Oregon Reproductive Medicine, 808 SW 15th Avenue, Portland, OR 97205, USA. Electronic address:
The evolution of preimplantation genetic screening (PGS) for aneuploidy to blastocyst biopsy and more sensitive 24-chromosome screening techniques has resulted in a new diagnostic category of PGS results: those classified as mosaic. This diagnosis presents significant challenges for clinicians in developing policies regarding transfer and storage of such embryos, as well as in providing genetic counselling for patients prior to and following PGS. Given the high frequency of mosaic PGS results and the wide range of possible associated outcomes, there is an urgent need to understand how to appropriately counsel patients regarding such embryos.
View Article and Find Full Text PDFReprod Sci
September 2017
3 Department of Obstetrics and Gynecology, New York University Fertility Center, New York, NY, USA.
Although controversial, increasing paternal age has been shown to negatively affect assisted reproductive technology (ART) outcomes and success rates. Most studies investigating the effect of paternal age on ART outcomes use a donor oocyte model to minimize maternal aneuploidy contribution. This study sought to determine whether increasing paternal age is associated with adverse in vitro fertilization (IVF) outcomes when aneuploidy is minimized using preimplantation genetic screening.
View Article and Find Full Text PDFFertil Steril
January 2017
New York University Fertility Center, New York University Langone Medical Center, New York, New York.
Curr Opin Endocrinol Diabetes Obes
December 2016
New York University Fertility Center (NYUFC), NYU Langone Medical Center, New York, New York, USA.
Purpose Of Review: Elective oocyte cryopreservation for deferred childbearing has gained popularity worldwide, commensurate with increased knowledge regarding age-related fertility decline. The purpose of this review is to summarize recent data regarding trends in delayed childbearing, review recent findings surrounding age-related fertility decline, acknowledge significant gaps in knowledge among patients and providers regarding fertility decline and review outcomes following elective oocyte cryopreservation.
Recent Findings: Despite an inevitable decline in fertility and increase in miscarriage with increasing female age, there is a growing worldwide trend to delay childbearing.
Fertil Steril
November 2016
New York University Langone Medical Center, New York University Fertility Center, New York, New York.
Objective: To determine whether undetected aneuploidy contributes to pregnancy loss after transfer of euploid embryos that have undergone array comparative genomic hybridization (aCGH).
Design: Case-control study.
Setting: University-based fertility center.
J Genet Couns
December 2016
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, New York University Langone Medical Center, New York, NY, 10016, USA.
Pre-implantation genetic diagnosis (PGD) has changed the landscape of clinical genetics by helping families reduce the transmission of monogenic disorders. However, given the high prevalence of embryonic aneuploidy, particularly in patients of advanced reproductive age, unaffected embryos remain at high risk of implantation failure or pregnancy loss due to aneuploidy. 24-chromosome aneuploidy screening has become widely utilized in routine in vitro fertilization (IVF) to pre-select embryos with greater pregnancy potential, but concurrent 24-chromosome aneuploidy screening has not become standard practice in embryos biopsied for PGD.
View Article and Find Full Text PDFJ Assist Reprod Genet
November 2016
New York University Fertility Center, 660 First Avenue 5th floor, New York, NY, 10016, USA.
Purpose: The aim of this study was to report the results of IVF with trophectoderm biopsy and preimplantation genetic screening (PGS) following delayed intracytoplasmic sperm injection (ICSI).
Methods: Patients undergoing IVF with PGS and delayed ICSI were included in the study. Indications for delayed ICSI included absent or poor fertilization via standard insemination or more than 50 % immature oocytes, noted post-cumulus stripping for standard ICSI procedure.
J Assist Reprod Genet
July 2016
New York University Fertility Center, New York University School of Medicine, 660 First Avenue, 5th floor, New York, NY, 10016, USA.
Purpose: Preimplantation genetic screening (PGS) and diagnosis (PGD) with euploid embryo transfer is associated with improved implantation and live birth rates as compared to routine in vitro fertilization. However, misdiagnosis of the embryo is a potential risk. The purpose of this study was to investigate the clinical discrepant diagnosis rate associated with transfer of trophectoderm-biopsied blastocysts deemed to be euploid via array comparative genomic hybridization (aCGH).
View Article and Find Full Text PDFReprod Biol Endocrinol
May 2015
New York University Fertility Center, New York University School of Medicine, New York, New York, 10016, USA.
Background: Low functional ovarian reserve (LFOR) has been associated with hypoandrogenemia and increased embryo aneuploidy, while androgen supplementation has been reported to improve aneuploidy rates. We, therefore, assessed whether in infertile women undergoing in vitro fertilization (IVF) androgen concentrations are associated with aneuploidy rates.
Methods: This study was performed in 2 academically affiliated fertility centers in New York City and an academically affiliated steroid chemistry laboratory in Utah.
Fertil Steril
April 2015
New York University Fertility Center, Langone Medical Center, New York University, New York, New York.
Objective: To compare the euploidy outcome in patients that underwent 2 ovarian stimulation cycles with trophectoderm biopsy.
Design: Retrospective repeated-measures cohort study.
Setting: University-based fertility center.
Fertil Steril
March 2015
New York University Fertility Center, New York University Langone Medical Center, New York, New York.
Objective: To determine whether an association exists between body mass index (BMI) and embryo ploidy in patients undergoing in vitro fertilization (IVF) with trophectoderm biopsy and 24-chromosome preimplantation genetic screening (PGS).
Design: Retrospective cohort study.
Setting: University-based fertility center.
J Assist Reprod Genet
February 2015
New York University Fertility Center, New York University Langone Medical Center, 660 First Ave, 5th Floor, New York, NY, 10016, USA,
Purpose: To determine if day of embryo transfer (ET) affects gestational age (GA) and/or birth weight (BW) at a single university fertility center that primarily performs day 5/6 ET.
Methods: Retrospective cohort study of 2392 singleton live births resulting from IVF/ICSI at a single large university fertility center from 2003 to 2012. Patients were stratified by day 3 or day 5/6 ET.
Fertil Steril
March 2015
New York University Fertility Center, New York University School of Medicine, New York, New York.
Objective: To determine if long-term cryopreservation of human oocytes affects oocyte developmental competence, blastocyst euploidy, or live-birth rates.
Design: Retrospective cohort study.
Setting: University-based fertility center.
Fertil Steril
February 2015
New York University Fertility Center, New York University Langone Medical Center, New York, New York.
Objective: To determine the relationship between blastocyst growth parameters and birth weight.
Design: Cohort study.
Setting: University-affiliated fertility center.
Fertil Steril
November 2014
New York University Fertility Center, Langone Medical Center, New York University, New York, New York.
Objective: To consider how staffing requirements have changed with evolving and increasingly more complex assisted reproduction technology (ART) laboratory practice.
Design: Analysis by four laboratory directors from three different ART programs of the level of complexity and time requirements for contemporary ART laboratory activities to determine adequate staffing levels.
Setting: University-based and private ART programs.
J Med Genet
August 2014
Reprogenetics LLC, Livingston, New Jersey, USA.
Background: The majority of human embryos created using in vitro fertilisation (IVF) techniques are aneuploid. Comprehensive chromosome screening methods, applicable to single cells biopsied from preimplantation embryos, allow reliable identification and transfer of euploid embryos. Recently, randomised trials using such methods have indicated that aneuploidy screening improves IVF success rates.
View Article and Find Full Text PDFFertil Steril
September 2014
Colorado Center for Reproductive Medicine, Englewood, Colorado.
Reprod Biomed Online
April 2014
New York University Fertility Center, New York University Langone School of Medicine, 660 1st Ave., 5th Floor, New York, NY 10016, United States.
Preimplantation genetic diagnosis and screening improves the chances of achieving a viable pregnancy, not only free of undesired single-gene defects but also aneuploidy. In addition, improvements in vitrification provide an efficient means of preserving embryos (blastocysts). By combining trophectoderm biopsy with recent improvements in vitrification methods, only those embryos that have proved themselves viable and potentially more competent are tested.
View Article and Find Full Text PDF